<SEC-DOCUMENT>0001437749-24-031265.txt : 20241015
<SEC-HEADER>0001437749-24-031265.hdr.sgml : 20241015
<ACCEPTANCE-DATETIME>20241015164316
ACCESSION NUMBER:		0001437749-24-031265
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20241015
DATE AS OF CHANGE:		20241015

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GeoVax Labs, Inc.
		CENTRAL INDEX KEY:			0000832489
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				870455038
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-277585
		FILM NUMBER:		241372366

	BUSINESS ADDRESS:	
		STREET 1:		1900 LAKE PARK DRIVE
		STREET 2:		SUITE 380
		CITY:			SMYRNA
		STATE:			GA
		ZIP:			30080
		BUSINESS PHONE:		678-384-7220

	MAIL ADDRESS:	
		STREET 1:		1900 LAKE PARK DRIVE
		STREET 2:		SUITE 380
		CITY:			SMYRNA
		STATE:			GA
		ZIP:			30080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Geovax Labs, Inc.
		DATE OF NAME CHANGE:	20061002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DAUPHIN TECHNOLOGY INC
		DATE OF NAME CHANGE:	19940826

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SUCCESSO INC
		DATE OF NAME CHANGE:	19910410
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>govx20241014_424b5.htm
<DESCRIPTION>FORM 424B5
<TEXT>
<html><head>
	<title>govx20241014_424b5.htm</title>

	<!-- Generated by ThunderDome Portal - 10/15/2024 4:12:58 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size:10pt;font-family:'Times New Roman';padding:0in .1in;">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>Filed Pursuant to Rule 424(b)(5)</b><br>
<b>Registration No. 333-277585</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>PROSPECTUS SUPPLEMENT</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>(To Prospectus Supplement Dated September 25, 2024</b><br>
<b>and accompanying Prospectus Dated March 13, 2024)</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="text-align:center;font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><img alt="govx20241014_424b5img001.jpg" src="govx20241014_424b5img001.jpg" style="width:393;height:109;"></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>GeoVax Labs, Inc.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Up to $30,000,000</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Common Stock</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">This prospectus supplement updates, amends and supplements certain information in the prospectus supplement, dated September 25, 2024 (the &#8220;Original Prospectus Supplement&#8221;), and the accompanying prospectus dated March 13, 2024 (collectively, the &#8220;Prior Prospectus&#8221;). This prospectus supplement should be read in conjunction with the Prior Prospectus, and is qualified by reference thereto, except to the extent that the information herein updates, amends or supplements the information contained in the Prior Prospectus. This prospectus supplement is not complete without, and may only be delivered or utilized in connection with, the Prior Prospectus, and any future amendments or supplements thereto.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Under the Prior Prospectus, we registered up to $4,486,846 of shares of our common stock, par value $0.001 per share (our &#8220;Common Stock&#8221;), relating to the offer and sale of our Common Stock time to time through or to A.G.P./Alliance Global Partners (&#8220;A.G.P.&#8221;), acting as sales agent or principal, in &#8220;at the market&#8221; offerings as defined in Rule 415 under the Securities Act of 1933, as amended, pursuant to that certain Sales Agreement, dated as of September 25, 2024, between us and A.G.P., as agent (the &#8220;Sales Agreement&#8221;). From September 25, 2024 through the date of this prospectus supplement, we sold an aggregate of 572,725 shares of our Common Stock for an aggregate purchase price of $1,257,464 under the Prior Prospectus.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">As of October 14, 2024, the aggregate market value of our outstanding common stock held by non-affiliates was approximately $75,590,412, which was calculated based on 9,052,744 shares of outstanding common stock held by non-affiliates, at a price per share of $8.35, the closing price of our common stock on August 21, 2024, the highest closing price of the Company&#8217;s common stock on the Nasdaq Capital Market during the preceding sixty (60) day trading period. Therefore, our public float has increased above $75.0 million and&nbsp;we are&nbsp;no longer subject&nbsp;to the sales limitations of General Instruction&nbsp;I.B.6.&nbsp;of Form S-3. As of the date of this prospectus supplement, we are increasing the aggregate amount of Common Stock that we are offering pursuant to the Sales Agreement, such that we are offering up to an aggregate of $30,000,000 of our Common Stock for sale under the Sales Agreement, including the shares of Common Stock previously sold, or $28,742,536 from and after the date hereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Our common stock is quoted on The Nasdaq Capital Market under the symbol &#8220;GOVX.&#8221; On October 14, 2024, the last reported sale price of our common stock was $2.01 per share.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Investing in our common stock involves significant risks. See</b>&nbsp;&#8220;<b><i>Risk Factors</i></b>&#8221;&nbsp;<b>beginning on page S-11 of the Original Prospectus Supplement, page 7 of the accompanying prospectus and under similar headings in the documents incorporated by reference into this prospectus supplement and the accompanying prospectus.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 16pt; font-variant: normal; text-align: center; margin: 0pt;"><b>A.G.P.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">The date of this prospectus supplement is October 15, 2024.</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>govx20241014_424b5img001.jpg
<TEXT>
begin 644 govx20241014_424b5img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !M 8D# 2(  A$! Q$!_\0
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M^TR@>?='<3WQ7:CM[5%16=D5"5UJ/I:9^=/J#0**** "BBD% "T444 %%%%
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M<VPW?0U[8.!6^)GM%&-)=10".M+@TM("#WKDL= 4@'XT[.*6F S'%(8PP^8
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MD5CZ*U2UD:-H\.C6BPH\DC?Q22')8UK]ZQ>Y:N,(YKFO$OA"PUZV;,:QW/\
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MW:*$6_D8+T#5<L,I.\63[5K1GT!N&.M5-3(.F77_ %R;^5>(GQUX@8Y^W_\
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I,)K@<*WH%]N]=LRJPVL 0>QI%B2)3L55'H!BJ4K*PK#NU+114H9__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
